Bio Screening Industry News

You still have time to submit your abstracts!

Call for Papers deadline extended to Friday, October 21st!

Great to learn about cutting-edge technologies. Also nice to hear the technology criticized by a panel - adds a realistic view.”
- R.B., RB Consulting

“It is clear that HTS process improvements can be applied to upstream and downstream drug discovery”
- C. H., Boehringer-Ingelheim

“Good to have a lot of networking opportunities. I have made some good contacts.”
- M.G., LDDN Harvard University

“The sessions are conducive to in-depth discussions of topics.”
- G.S., Exelixis Inc.

Year after year, these and many other scientists in the screening, assay development, target and therapeutic groups attend ScreenTech not only to find out where the industry is heading, and what the next hottest science & technology is, but also to meet old friends and make new acquaintances. ScreenTech, now into its 15th year, is an annual event that actively brings together the community of screeners, assay developers, data analyzers and interpreters, medicinal chemists in library design and compound profiling, as well as principal scientists in target classes and therapeutic area groups.

This year, ScreenTech 2006 will attempt to bring out the best yet in the science and technology of screening. We are now accepting oral abstracts on the following topics:

Comparison of HTS and their applications
Compound Prioritization & Compound Screening for Lead Discovery & Lead Optimization
Large vs. Focused Libraries
HCS in ADME /Tox Assessment
Target Validation using siRNA in HCS
Cell-based Assays in HCS
Label-free technologies
Functional Imaging
Physiology-based Screening
HCS for Biomarkers Discovery
HCS for Signaling Pathway Analysis
Imaging Informatics - Data Storage, Data Visualization & Management
Approaches to Data Interpretation & Analysis
Technology Idol Showcase (see below for more details)
Oral abstracts submitted should be case-study oriented and should demonstrate how the assay or screening technology, research method, design or process has helped improve and accelerate the drug discovery and development pipeline, reduce attrition, or improve quality of research. Each abstract should focus on the take-home messages which the participants might expect to get and implement in their own research work.

All abstracts should be submitted online at www.IBCLifeSciences.com/ScreenTech.

——————————————————————————–

Special Feature:
CALL FOR TECHNOLOGY IDOL

Concept and Process
The Technology Idol session will be held in the Exhibit Hall, which will feature exciting novel & emerging technologies. These presentations will describe the use and benefits of the technology from a user’s perspective so that the panel can get a sense of the value of that technology to the industry.

Format:
Each talk will offer a short 10-minute overview of the technology, and this will be followed by a brief critique by judges selected from the screening operations of major pharmaceutical companies.

Ballot/Judging:
Ballot boxes will be set up on the exhibit floor and all audience will be encouraged to cast their vote for the Best Idol. Winners will be announced during the conference.

Who May Present:
Presentations in this session will be given either by industry scientists, who are users of the technology, or by scientists from the presenting company. Business development or marketing professionals will not be eligible to give these presentations.

Technology Idol Presentation Content:
Each presentation is expected to provide a concise and scientific explanation about the capabilities of the method or technology - perhaps in the context of a short case study. Marketing or business development content will not be allowed in these presentations. If such content arises, the judging panel will point out that circumstance - to the possible detriment of the presenter.

Submit your abstract for Technology Idol showcase at www.IBCLifeSciences.com/ScreenTech.